UKTI Logo Sitemap | Help
Text size: a  a  a Home About Us How We Help Contact Us Events Downloads OurWorld  
 
 
My UK
Create email alerts
 
Why the UK?
Key advantages Business factors Investment regions Forming a company Living & leisure
 
Your business sector
Aerospace Automotive Creative industries Environment & renewable energy Financial services Food & drink ICT Life sciences Nanotechnology More sectors
 
UK advisory network
Welcome to the network Get professional advice Give professional advice Network news & events
OurWorld…passionate about business21-Aug-08
Welcome to UK Trade & Investment today

Laboratory of Molecular Biology to be re-built

A pioneering UK laboratory will undertake a £200-million programme to upgrade its facilities.

The Department for Innovation, Universities and Skills has announced that the Laboratory of Molecular Biology will see its 40-year old building replaced with state-of-the-art laboratory facilities, which will allow research to branch out into areas such as neurobiology.

'

Investment in the redevelopment of the Laboratory of Molecular Biology is to provide a cutting-edge research environment

John Denham

Secretary of State for Innovation, Universities and Skills

'

Efforts to commercialise the results of the Cambridge laboratory's research efforts will also be enhanced by the new building.

The Laboratory of Molecular Biology is one of the highlights of the UK's research sector, being responsible for discovering the structure of DNA, developing DNA sequencing technology and producing 13 Nobel Prize winners.

John Denham, Secretary of State for Innovation, Universities and Skills, commented: "Investment in the redevelopment of the Laboratory of Molecular Biology is to provide a cutting-edge research environment. It will help retain and attract some of the world's best scientists working on medical research.

The UK’s Life Sciences opportunities

Find out more about the Life Sciences sector in the UK

Denham also drew attention to the achievements of the facility, including research into monoclonal antibodies to treat asthma and the companies that have spun out from its activities.

Sir Leszek Borysiewicz, the Medical Research Council Chief Executive, added the investment would back up the laboratory's position as a "globally-competitive research centre".

The facility employs almost 400 staff and carries out research into a wide range of disciplines, including biochemistry, genetics, mathematics and physics.



How can we help you?

Discover how our global network of business champions can help you achieve your goals.

We have personalised services for foreign investors, consultants, media/press, and students.